Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oncocyte Corp (NQ: OCX )

0.3900 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 252,259
Open 0.3700
Bid (Size) 0.3730 (1)
Ask (Size) 0.4000 (4)
Prev. Close 0.3900
Today's Range 0.3700 - 0.4000
52wk Range 0.2418 - 1.750
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday! 
Via InvestorPlace

Performance

YTD
+13.04%
+13.04%
1 Month
+5.41%
+5.41%
3 Month
-40.61%
-40.61%
6 Month
-58.93%
-58.93%
1 Year
-76.92%
-76.92%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
OncoCyte's Return On Capital Employed Insights
Via Benzinga
Precision Diagnostics Company Oncocyte Cuts 40% Of Its Workforce
Via Benzinga
Analyst Ratings for OncoCyte
Via Benzinga
Expert Ratings for OncoCyte
Via Benzinga
Oncocyte Implements Cost Reduction Initiatives, Realigns Operations
Via Benzinga
GlycoMimetics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Via Benzinga
Oncocyte Enters $2B Market With Transplant Rejection Monitoring Test
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
OncoCyte And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
Via Benzinga
Expert Ratings for OncoCyte
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
Via Benzinga
Oncocyte Reports That Its First-Of-Its-Kind DetermaCNI Blood Test That Tracks Cancer Treatment Progress Could Hit Market By 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.